Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
aria sico
sico societa' italiana carburo ossigeno s.p.a. - aria medicale - aria medicale
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
aria medicair
medicair italia s.r.l. - aria medicale - aria medicale
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
flutiform 50/5 druckgasinhalation, suspension
mundipharma medical company, hamilton, bermuda, basel branch - fluticasoni propionas, formoteroli fumaras dihydricus - druckgasinhalation, suspension - fluticasoni propionas 50 µg pro dosi, formoteroli fumaras dihydricus 5 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. - asma bronchiale - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
flutiform 125/5 druckgasinhalation, suspension
mundipharma medical company, hamilton, bermuda, basel branch - fluticasoni propionas, formoteroli fumaras dihydricus - druckgasinhalation, suspension - fluticasoni propionas 125 µg pro dosi, formoteroli fumaras dihydricus 5 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. - asma bronchiale - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
flutiform 250/10 druckgasinhalation, suspension
mundipharma medical company, hamilton, bermuda, basel branch - fluticasoni propionas, formoteroli fumaras dihydricus - druckgasinhalation, suspension - fluticasoni propionas 250 µg pro dosi, formoteroli fumaras dihydricus 10 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. - asma bronchiale - synthetika
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
aria linde medicale
linde medicale srl - aria medicale - aria medicale
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
aria ossigas
nippon gases pharma s.r.l. - aria medicale - aria medicale
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
aria criosalento
criosalento s.r.l. - aria medicale - aria medicale
Unione Europea -
italiano -
EMA (European Medicines Agency)
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
Unione Europea -
italiano -
EMA (European Medicines Agency)
xtandi
astellas pharma europe b.v. - enzalutamide - neoplasie prostatiche - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.